Loading...

FITC anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_FITC_011409.jpg
C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
  • HK1dot4_FITC_011409.jpg
    C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
128005 50 µg £61
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128006 500 µg £201
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  2. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  3. Zaman R, et al. 2021. Immunity. :. PubMed
  4. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  5. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  6. Fang C, et al. 2022. J Pathol. 256:310. PubMed
  7. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  8. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  9. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  10. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  11. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  12. Campisi L, et al. 2022. Nature. 606:945. PubMed
  13. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  14. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  15. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  16. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  17. Soni N, et al. 2022. FASEB Bioadv. 4:798. PubMed
  18. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  19. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  20. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  21. Hettwer J, et al. 2022. Cardiovasc Res. 118:2778. PubMed
  22. Fernández-García V, et al. 2022. Biomed Pharmacother. 148:112769. PubMed
  23. Chen K, et al. 2022. Adv Sci (Weinh). 9:e2104106. PubMed
  24. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  25. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  26. Sanmarco LM, et al. 2022. Nature. 611:801. PubMed
  27. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  28. Aso K, et al. 2023. Nat Commun. 14:984. PubMed
  29. Bautista CA, et al. 2023. Front Physiol. 14:1122348. PubMed
  30. He Y, et al. 2023. Biomolecules. 13:. PubMed
  31. Lin CH, et al. 2023. iScience. 26:106904. PubMed
  32. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  33. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  34. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  35. Duan Y, et al. 2019. Circ Res. 125:969. PubMed
  36. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  37. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  38. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  39. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
  40. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  41. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  42. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  43. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  44. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  45. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  46. You Y, et al. 2016. Sci Rep. 6:20630. PubMed
  47. Dong L, et al. 2021. Cancer Cell. . PubMed
  48. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  49. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  50. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  51. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  52. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  53. Buzas K, et al. 2011. Cytokine. 55:429. PubMed
  54. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  55. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  56. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  57. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  58. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  59. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  60. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  61. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  62. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  63. McAlpine CS, et al. 2019. Nature. 566:383. PubMed
  64. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  65. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  66. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  67. Mirakaj V, et al. 2014. J Exp Med. 211:1037. PubMed
  68. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
  69. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  70. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  71. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  72. Al-Sharea A, et al. 2017. Cell Cycle. 10.1016/j.atherosclerosis.2017.08.010. PubMed
  73. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  74. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  75. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  76. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  77. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  78. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  79. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  80. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  81. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  82. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  83. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  84. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  85. Cao Y, et al. 2015. J Biol Chem. 290: 23050-23063. PubMed
  86. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  87. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  88. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  89. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  90. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  91. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  92. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  93. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  94. Xu Y, et al. 2016. Arthritis Rheum. 67: 225-237. PubMed
  95. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  96. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  97. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  98. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  99. Körner A,et al. 2017. Cell Death Differ.. 10.1038/cdd.2017.177. PubMed
  100. He J, et al. 2019. J Clin Invest. 130. PubMed
  101. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  102. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  103. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  104. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  105. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  106. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  107. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  108. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  109. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  110. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  111. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  112. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  113. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  114. Lee S, et al. 2011. J Immunol. 186:6972. PubMed
  115. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  116. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  117. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  118. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
  119. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  120. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  121. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  122. Alvarez-Breckenridge C, et al. 2012. J Virol. 86:4566. PubMed
  123. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  124. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  125. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
  126. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  127. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  128. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  129. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  130. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  131. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  132. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  133. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  134. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  135. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  136. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  137. Tyagi A, et al. 2021. Nat Commun. 12:474. PubMed
  138. Tang S, et al. 2022. Virol J. 19:32. PubMed
  139. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  140. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  141. Caballero S, et al. 2017. Invest Ophthalmol Vis Sci. 58:5164. PubMed
  142. Rahtes A, et al. 2020. Front Immunol. 1.484722222. PubMed
  143. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  144. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  145. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  146. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  147. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  148. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  149. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  150. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  151. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  152. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  153. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  154. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  155. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  156. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  157. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  158. Jones GS, et al. 2020. mSphere. 5:. PubMed
  159. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  160. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  161. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  162. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  163. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  164. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  165. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  166. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
RRID
AB_1186134 (BioLegend Cat. No. 128005)
AB_1186135 (BioLegend Cat. No. 128006)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6C Reagents Request Custom Conjugation
Description Clone Applications
Pacific Blue™ anti-mouse Ly-6C HK1.4 FC
APC anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C HK1.4 FC,IHC-F
Biotin anti-mouse Ly-6C HK1.4 FC
FITC anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 647 anti-mouse Ly-6C HK1.4 FC
PE anti-mouse Ly-6C HK1.4 FC
PerCP/Cyanine5.5 anti-mouse Ly-6C HK1.4 FC
PE/Cyanine7 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 488 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 700 anti-mouse Ly-6C HK1.4 FC
APC/Cyanine7 anti-mouse Ly-6C HK1.4 FC
PerCP anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 570™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 421™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 510™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 605™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 711™ anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C (Maxpar® Ready) HK1.4 FC,CyTOF®
Brilliant Violet 785™ anti-mouse Ly-6C HK1.4 FC
PE/Dazzle™ 594 anti-mouse Ly-6C HK1.4 FC
APC/Fire™ 750 anti-mouse Ly-6C HK1.4 FC
TotalSeq™-A0013 anti-mouse Ly-6C HK1.4 PG
Brilliant Violet 650™ anti-mouse Ly-6C HK1.4 FC
TotalSeq™-C0013 anti-mouse Ly-6C HK1.4 PG
TotalSeq™-B0013 anti-mouse Ly-6C HK1.4 PG
APC/Fire™ 810 anti-mouse Ly-6C Antibody HK1.4 FC
Spark Red™ 718 anti-mouse Ly-6C HK1.4 FC
Spark UV™ 387 anti-mouse Ly-6C HK1.4 FC
PE/Fire™ 810 anti-mouse Ly-6C HK1.4 FC
Spark Blue™ 550 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
Spark Blue™ 574 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
PE/Cyanine5 anti-mouse Ly-6C HK1.4 FC
Spark PLUS B550™ anti-mouse Ly-6C HK1.4 FC
PerCP/Fire™ 806 anti-mouse Ly-6c Antibody HK1.4 FC
Go To Top Version: 2    Revision Date: 12/09/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account